ARTICLE
|
doi:10.20944/preprints202209.0198.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Cholecystokinin-2 receptor; minigastrin; peptide receptor radionuclide therapy; lutetium-177, theranostics
Online: 14 September 2022 (08:39:42 CEST)